Choose another country or region to see content specific to your location
United States
Choose country or region
Continue
MOR_CFD

Morphosys AG

Morphosys AG is a leading German biotechnology company that specializes in developing innovative therapeutic antibodies for treating various diseases. The company's proprietary technology platform, HuCAL, enables the rapid and efficient generation of fully human antibodies, which have a higher success rate in clinical trials and lower risk of side effects than traditional antibodies. Morphosys has a diverse pipeline of drug candidates in various stages of development, targeting indications such as cancer, autoimmune disorders, and infectious diseases. The company also collaborates with pharmaceutical partners to develop and commercialize its drug candidates. Morphosys is dedicated to improving patient outcomes by creating novel and effective therapies.

Instrument specification for Morphosys AG

Start trading now with fast account opening.

Sign-up now to trade the most active markets

Open account
Boasting over 20 years in the markets, leading analysis tools and thousands of satisfied clients, OANDA is proud to be an award-winning broker.
Get access to the most active of global markets with thousands of trading instruments at your fingertips, as well leading technical tools to assist in your analysis.
Trade without unnecessary costs and total pricing transparency - OANDA offers zero-commission on major instruments, transparent pricing.
Scroll to top